Satellite Banner
Technology Networks Header
Sunday, September 21, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Bio-Rad Launches Precision Blue™ Real-Time PCR Dye
Friday, April 04, 2014
Bio-Rad Laboratories, Inc. today announced the launch of its Precision Blue real-time PCR dye, making it easier for researchers to set up real-time PCR (qPCR) experiments.

Cancer Genetics Expands BioDiscovery's Nexus Copy Number Platform
Thursday, April 03, 2014
Expansion to identify novel biomarkers predictive of cancer outcomes.

Identifying Epigenetic Biomarkers for Prostate Cancer
Tuesday, April 01, 2014
IDT qPCR assays and probes facilitate the development of predictive epigenetic biomarkers.

Techne’s New In Situ Hybridization Adapter
Friday, March 28, 2014
Delivers a quick, economical solution for 96-well thermal cycler owners.

GenTegra LLC Launches New RNA Ambient Stabilization Product
Friday, March 28, 2014
Protect RNA samples immediately, and for all its tomorrows.

AbsoluteIDQ® p180 by BIOCRATES Life Sciences AG
Tuesday, March 25, 2014
Cutting-edge test kit made in Austria helps develop the world’s first metabolomics-based blood test to predict Alzheimer’s disease.

Human Taste Sensation can now be Investigated on a Molecular Level
Thursday, March 20, 2014
SIRION Biotech provides adenovirus to transduce proliferation-promoting genes to viable human taste cells from fungiform papillae.

Molecular Devices to Showcase Next Generation SpectraMax® MiniMax™ 300 Imaging Cytometer at Analytica
Wednesday, March 19, 2014
SpectraMax® MiniMax™ 300 imaging cytometer enables both cellular visualization and first-of-its-kind stain free cell-based analysis on the field-upgradable SpectraMax®i3 Multi-Mode Microplate Reader.

Eppendorf Launches New Mastercycler nexus X2
Friday, March 14, 2014
Provides solution for simultaneous PCR runs.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 713
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv